$118.13
0.31% yesterday
NYSE, Nov 25, 10:14 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$118.13
+3.91 3.42% 1M
+14.18 13.64% 6M
+8.06 7.32% YTD
+15.42 15.01% 1Y
-6.94 5.55% 3Y
+33.64 39.82% 5Y
+73.97 167.50% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.37 0.31%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Market capitalization $204.89b
Enterprise Value $212.31b
P/E (TTM) P/E ratio 35.92
EV/FCF (TTM) EV/FCF 32.73
EV/Sales (TTM) EV/Sales 5.15
P/S ratio (TTM) P/S ratio 4.97
P/B ratio (TTM) P/B ratio 5.15
Dividend yield 1.76%
Last dividend (FY23) $2.08
Revenue growth (TTM) Revenue growth 3.15%
Revenue (TTM) Revenue $41.22b
EBIT (operating result TTM) EBIT $6.75b
Free Cash Flow (TTM) Free Cash Flow $6.49b
Cash position $7.79b
EPS (TTM) EPS $3.29
P/E forward 34.71
P/S forward 4.88
EV/Sales forward 5.05
Short interest 0.82%
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Abbott Laboratories forecast:

21x Buy
72%
8x Hold
28%

Analyst Opinions

29 Analysts have issued a Abbott Laboratories forecast:

Buy
72%
Hold
28%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
41,217 41,217
3% 3%
100%
- Direct Costs 20,206 20,206
0% 0%
49%
21,011 21,011
6% 6%
51%
- Selling and Administrative Expenses 8,251 8,251
6% 6%
20%
- Research and Development Expense 2,783 2,783
2% 2%
7%
9,977 9,977
8% 8%
24%
- Depreciation and Amortization 3,224 3,224
0% 0%
8%
EBIT (Operating Income) EBIT 6,753 6,753
12% 12%
16%
Net Profit 5,745 5,745
12% 12%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Neutral
PRNewsWire
one day ago
The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart valve disease The investigational system is designed to offer best-in-class heart blood flow, ease of use and precision Approximately 9% of older Americans have aortic stenosis1 ABBOTT PARK, Ill., Nov. 25, 2024 /PRNewswi...
Neutral
Seeking Alpha
one day ago
Abbott has a very stable gross profit margin, while the company's revenue and return on invested capital could be more consistent. The company has increased their dividend for more than 50 years and should announce their 53rd dividend increase in December. Considering ABT is trading for a slight premium and has a long-term expected rate of return of 8%, potential investors will need to be patient.
Neutral
The Motley Fool
4 days ago
2 Dividend Kings to Buy for a Lifetime of Passive Income
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today